ABOUT US
Neurodiversity
at a glance
At QuantaBrain, we develop software to diagnose and suggest personalized treatments for neurodevelopmental and neuropsychiatric disorders using a quick 1-minute magnetic resonance (MR) exam.
Our method identifies changes in brain activity and gives clear, objective and
quantitative results.
Many neurodevelopmental and
neuropsychiatric disorders that currently fall
under the same disease category have very
different biological bases. Our method
extracts individual brain activity signatures that prove invaluable in crafting individualized
treatment plans.
Patient safety is a top priority.
Our test is safe – it does not require sedation, and it does not use harmful radiation.
TECHNOLOGY
AI-powered MRI to identify
atypical brain activity
QuantaBrain has pioneered proprietary
AI-driven software for diagnosing psychiatric disorders through a quick 1-minute resting state functional magnetic resonance imaging (rs-fMRI) examination.
rs-fMRI is an entirely safe and non-invasive procedure where the patient simply rests (with the option to keep their eyes open or closed) for 1 minute inside the magnetic resonance scanner. Unlike structural imaging, functional MRI measures the flow of oxygenated blood in the brain. As neural activity consumes oxygen, this examination provides an indirect measurement of brain activity.
Our proprietary AI software leverages urban traffic analysis techniques to analyze how oxygen is delivered and consumed across the brain. It is compatible with any scanner and MR acquisition sequence.
TEAM
We are a multidisciplinary team
with expertise in: AI, medical imaging, genetics
and neurophysiology
Our common belief?
The next major health challenge lies in psychiatry
The next major health challenge lies in psychiatry
ELISA FERRARI
CEO and co-founder
PIETRO CARRA
CTO
HANNAH TEICHMANN
Co-founder and advisor
CEO of MedRA
DAVIDE BACCIU
Co-founder
Professor of AI at University of Pisa
ALESSANDRO CELLERINO
Co-founder
Professor of Neurogenetics at Normale
ALESSANDRA RETICO
Co-founder
Researcher at INFN
FRANCESCO PEZCOLLER
Legal advisor
Expert of venture capital and private equity
SALVATORE VISCOMI
Strategic advisor
CEO and co-founder of Carna Health
NEWS
Latest updates
CONTACTS